Back to results
US 2021/0002240 A1Published application
Inhibitors of phospholipid synthesis and methods of use
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsArvin Gouw, Dean W. Felsher, Feng Jin, Richard N. Zare, Katherine Margulis, Steven R. Schow, Robert J. Greenhouse, David Loughhead, Steven Richards
Life of this patent
Estimating the term…
Abstract
Inhibitors of Glycerol 3-Phosphate Acyltransferase (GPAT) are provided; and methods of use in the treatment of cancer; and treatment of conditions relating to metabolic syndrome and hyperlipidemia.
Claims45
A GPAT inhibitor of one of formulae (IA), (IB), (IC) or (II):
- wherein:
- R1 is selected from deuterated alkyl and substituted deuterated alkyl;
- R2, R3 and R5 are each independently selected from alkyl, substituted alkyl, deuterated alkyl and substituted deuterated alkyl;
- R4 is selected from alkyl, substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl(alkyl), heterocycloalkyl, heterocycloalkyl(alkyl), aryl, substituted aryl, aryl(alkyl), substituted aryl(alkyl), halo(alkyl), heteroaryl, heteroaryl(alkyl);
- or a pharmaceutically acceptable salt or solvate thereof.
2 more elements
Dependencies are inferred from the claim text.